Unknown

Dataset Information

0

Immunogenicity of a fusion protein containing immunodominant epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in mice and active TB infection.


ABSTRACT: Tuberculosis (TB) remains a major global health problem. The only vaccine against tuberculosis, attenuated Mycobacterium bovis Bacillus Calmette-Guerin (BCG), has demonstrated relatively low efficacy and does not provide satisfactory protection against the disease in adults. More effective vaccines and better therapies are urgently needed to reduce the global spread of TB. This study evaluated the immunogenicity of a recombinant M. tuberculosis Ag85C-MPT51-HspX fusion protein (CMX) in mice and individuals with active tuberculosis. BALB/c mice were immunized with the CMX protein liposome-encapsulated with CpG DNA or with CpGDNA liposome-encapsulated, liposome or saline as negative controls. The immunization produced high levels of anti-CMX -specific IgG1 and IgG2a antibodies and induced an increase in the relative and absolute numbers of specific TCD4 IFN-?(+) and TNF-?(+) cells in the spleen. Sera from a cohort of individuals with active tuberculosis contained higher levels of IgG and IgM that recognized CMX when compared to healthy individuals. In conclusion, this protein was shown to be immunogenic both in mice and humans.

SUBMITTER: de Sousa EM 

PROVIDER: S-EPMC3485045 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4232451 | BioStudies
2013-01-01 | S-EPMC3826754 | BioStudies
2012-01-01 | S-EPMC3440320 | BioStudies
2017-01-01 | S-EPMC5558980 | BioStudies
2012-01-01 | S-EPMC3511932 | BioStudies
2016-01-01 | S-EPMC5031420 | BioStudies
2014-01-01 | S-EPMC4130790 | BioStudies
2020-01-01 | S-EPMC7272080 | BioStudies
2019-01-01 | S-EPMC6787098 | BioStudies
1000-01-01 | S-EPMC175524 | BioStudies